Skip to main content
. Author manuscript; available in PMC: 2008 Dec 20.
Published in final edited form as: Int Immunopharmacol. 2007 Jul 27;7(14):1900–1908. doi: 10.1016/j.intimp.2007.07.007

Fig. 5.

Fig. 5

Inactivation and reactivation pathways of β-tryptase. Active β-tryptase tetramer converts to inactive monomers in the absence of heparin at pH 7.4, probably through an inactive tetrameric intermediate, though an active monomeric intermediate has not been excluded. Inactive β-tryptase monomers become active as monomers at low concentrations when at pH 6.0 in the presence of heparin. Active β-tryptase monomers convert to active tetramers at higher concentrations. B12 Fab mAb modulates β-tryptase activity by converting tetramers to monomers that are enzymatically active at pH 6.0, but inactive at pH 7.4.